a highly divergent proviral dna clone of siv from a distinct species of african green monkey.

NLM AIDSLINE A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Fomsgaard A; Hirsch VM; Allan JS; Johnson PR; Department of
August 30, 1991

Virology. 1991 May;182(1):397-402. Unique Identifier : AIDSLINE Simian immunodeficiency viruses from African green monkeys (SIVagm) are the most genetically heterogeneous type of non-human primate lentivirus. To further examine the extent of genetic divergence within the SIVagm type, we generated and sequenced a biologically active proviral DNA clone representing a lentivirus isolated from a distinct African green monkey species (grivet). Overall, this clone (gri-1/lambda II) was highly divergent from previously characterized SIVagm clones. Specifically, the difference between gri-1/lambda II and other SIVagm clones approximated the difference between the caprine arthritis encephalitis virus and visna virus (two biologically and genetically distinct ruminant lentiviruses). Our data suggest that lentiviruses from African green monkeys may have evolved in concert with speciation of the genus and support the concept that SIVagm may be the oldest primate lentivirus type in existence. Amino Acid Sequence Animal Cercopithecus aethiops/MICROBIOLOGY Cloning, Molecular Comparative Study DNA, Viral/GENETICS Gene Products, rev/GENETICS Gene Products, tat/GENETICS Gene Products, vif/GENETICS Molecular Sequence Data Support, U.S. Gov't, P.H.S. SIV/*GENETICS Viral Proteins/GENETICS JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Policy change has yet to affect HIV-positive sailors Immune system cancer drugs tipped to be a $35 billion market Big jump in HIV among Navajo in New Mexico Peace Corps to accept same-sex couples UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims PENNSYLVANIA: Area Residents Screened for Hepatitis C on Sunday COLORADO: Peer to Peer: Teens Work to Educate Peers on Pregnancy, STDs at CCHS OREGON: Portland Barefoot 3 x 3 Benefit Tournament to Draw Hundreds to Northeast Portland TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain One in 10 South Africans HIV positive AFRICA: Less-Used HIV Treatment for African Children More Effective Less-Used HIV Treatment for African Children More Effective NEW JERSEY: Morristown Nonprofit Spearheads NJ AIDS Walk, May 5 on the Green SOUTH AFRICA: South African Clinics Already Achieving Zero New HIV Infections in Children SOUTH AFRICA: South African Clinics Already Achieving Zero New HIV Infections in Children South African Viewers Hooked on AIDS-themed Show Mylan Delivers Much-anticipated "One Pill Once a Day" Triple Fixed-dose Antiretroviral Combination to the South African National Department of Health Fewer South Africans dying of HIV/AIDS, but more of diabetes Urgent humanitarian needs in post-coup Central African Republic
Information in this article was accurate in August 30, 1991. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.